Hongkongers to pay only HK$240 a year for leukaemia drug after system shake-up
--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-05-06 20:34 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Labour & Workers, Drugs, World News, Environment & Climate
--------------------------------------------------------------------
Snippet:
Hospital Authority says it began subsidising Dasatinib in April, with patients previously paying up to HK$500,000 annually for treatment
--------------------------------------------------------------------